Reed, Steven

Publications

Sort by

Co-Author Network

selected publications

Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection. Parasites & vectors. 2025 Academic Article GET IT
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques. iScience. 2025 Academic Article GET IT
Times cited: 1
The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa. Vaccines. 2025 Academic Article GET IT
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients. Frontiers in microbiology. 2025 Academic Article GET IT
Times cited: 1
Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability. Journal of controlled release : official journal of the Controlled Release Society. 2024 Academic Article GET IT
Times cited: 3
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans. Frontiers in immunology. 2024 Academic Article GET IT
Make it a combo. Science translational medicine. 2024 Review GET IT
Times cited: 1
ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis. PloS one. 2024 Academic Article GET IT
Times cited: 5
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines. 2024 Academic Article GET IT
Times cited: 7
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation. Molecular therapy : the journal of the American Society of Gene Therapy. 2023 Academic Article GET IT
Times cited: 38
sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients. Frontiers in medicine. 2023 Academic Article GET IT
Times cited: 2
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. 2023 GET IT
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. 2023 GET IT
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Infectious diseases and therapy. 2023 Academic Article GET IT
Times cited: 21
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis. Vaccines. 2023 Academic Article GET IT
Times cited: 49
Association between asthma, rhinitis and atopic dermatitis with leprosy: A case-control study. Indian journal of dermatology, venereology and leprology. 2023 Academic Article GET IT
Times cited: 3
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. Tuberculosis (Edinburgh, Scotland). 2022 Academic Article GET IT
Times cited: 17
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease. Virulence. 2022 Academic Article GET IT
Times cited: 8
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. Pathogens (Basel, Switzerland). 2022 Review GET IT
Times cited: 7
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women. Vaccines. 2022 Academic Article GET IT
Times cited: 17
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations. Frontiers in microbiology. 2022 Academic Article GET IT
Times cited: 14
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21. NPJ vaccines. 2022 Academic Article GET IT
Times cited: 15
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines. 2021 Review GET IT
Times cited: 36
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant. Microorganisms. 2021 Academic Article GET IT
Times cited: 15
Novel polyprotein antigens designed for improved serodiagnosis of bovine tuberculosis. Veterinary immunology and immunopathology. 2021 Academic Article GET IT
Times cited: 7
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection. Memorias do Instituto Oswaldo Cruz. 2021 Academic Article GET IT
Times cited: 9
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PloS one. 2021 Academic Article GET IT
Times cited: 32
Evolution of antigen-specific immune responses in cutaneous leishmaniasis patients. Parasite immunology. 2021 Academic Article GET IT
Times cited: 2
Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases. Applied microbiology and biotechnology. 2021 Review GET IT
Times cited: 8
New horizons in adjuvants for vaccine development. Current opinion in immunology. 2020 Review GET IT
Times cited: 46
The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients. AMB Express. 2020 Academic Article GET IT
Times cited: 10
An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Science translational medicine. 2020 Academic Article GET IT
Times cited: 211
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates. Science immunology. 2020 Academic Article GET IT
Times cited: 109
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection. Molecular therapy. Methods & clinical development. 2020 Academic Article GET IT
Times cited: 86
Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection. Applied microbiology and biotechnology. 2020 Academic Article GET IT
Times cited: 6
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cells. Nanoscale. 2020 Academic Article GET IT
Times cited: 21
A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. Vaccine. 2019 Academic Article GET IT
Times cited: 27
Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine: X. 2019 Academic Article GET IT
Times cited: 22

more ...

less ...

Background

education and training

Ph.D., University of Montana 79
B.A., Whitman College 73
M.S., University of Montana 1977

Contact

full name

Steven Reed

primary email

sgr2002@med.cornell.edu

VIVO Weill Cornell Medical College

Steven Reed Adjunct Professor of Microbiology in Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email